We are monitoring the impact of COVID-19 on Clostridium Botulinum Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6950
Share on
Share on

Global Clostridium Botulinum Market Size, Share, Trends and Growth Analysis Report - By Product, End User, Distribution Channel and Region – Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 6950
Pages: 175

Clostridium Botulinum Market Size (2020 to 2025)

The global clostridium botulinum market size is expected to grow at an impressive CAGR in the coming next 5 years timespan. 

Botulism is a disease that causes paralysis and is caused by the bacteria Clostridium botulinum. Some symptoms include weakness, paralysis, vision and swallowing, breathing and speaking problems. The weakness further leads to fatigue of limb muscles. The symptoms are not caused by the bacterium itself but by the toxin produced by the bacterium.  

MARKET DRIVERS:

The major factors that drive the growth of the botulism market include lack of cleanliness in certain regions of the world and increase in awareness about disease and treatments, increase in R&D practices, and availability of efficient solutions for botulism. Besides, owing to strong efforts by WHO and CDC, the disease is getting irradiated slowly.

Y-O-Y growth in the population, rising significance for minimally invasive or non-invasive surgeries, and increasing investments for R&D activities are driving the global clostridium botulinum market growth. Growing incidences of botulism and increasing awareness regarding the diverse toxic bacteria are expected to favor the clostridium botulinum market development. The increasing number of government measures supporting R&D in the clinical healthcare sector and improved advanced treatment facilities are favorable signals to the market growth.

The increasing number of epidemic diseases, growing healthcare expenditure, and the interest of key market participants to set up their research centers are a big plus to the market growth. For instance, in 2016, Ipsen S.A. received the U.S FDA approval for its Dysport injection, and this injection is to treat children aged 2 years and above for pediatric lower limb (PLL), same is used in adults. In 2017, around 7.2 million botulinum injections were used in the United States for cosmetic procedures. The growing number of cosmetic aesthetic procedures successfully intensifies the market growth during the forecast period.

MARKET RESTRAINTS:

However, the high cost of research and development projects and government austerity are some of the hurdles expected to hinder the growth of the botulism market.

Impact of COVID-19 on the global clostridium botulinum market:

The World Health Organization (WHO) declared the coronavirus (COVID-19) as an emergency public health issue. Governments imposed nationwide lockdown was following strict rules to prevent the virus from the spread. All the hospitals were ordered to stop or cancel or postpone all the non-emergency medical procedures to bring the medical capacities in COVID-19 patients. The pandemic crisis has negatively affected the clostridium botulinum market. People who are suffering from this disease need to take injections every 3 to 4months. During the lockdown, a vast number of missed or canceled their treatment due to the coronavirus's fear. The advantages of botulinum toxin therapeutic are reused to improve COVID-19 intervened diverse pathological effects comprising pulmonary failure, cardiovascular defects, and neurological shortage observed in COVID-19 patients.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Product Type, Application, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

 

This research report on the global clostridium botulinum market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2025.

Clostridium Botulinum Market – By Product Type:

  • Botulinum Toxin Type A      
  • Botulinum Toxin Type B      

The botulinum toxin type A segment is expected to lead the global clostridium botulinum market. As per CDC, in 2016, in the United States, 102 botulinum cases were caused by toxin Type A.

Clostridium Botulinum Market – By Application:

  • Aesthetic 
  • Therapeutics   

Based on the application, the aesthetic segment accounted for a major share of the market. The aesthetic applications are used in the cosmetic industry for bettering facial appearance and decreasing aging symptoms. Growing R&D actions are broadening the usage of botulinum toxin (BOTOX) among different indications. As per the International Society of Plastic Surgery 2018, estimated growth in BOTOX procedures rose by 17.4% in 2018 compared to 2017. The people's issues about their look are flourishing in both the developed and developing countries of the world.

Clostridium Botulinum Market – By Distribution Channel:

  • Hospitals  
  • Clinics        
  • Retail pharmacies 

Based on the distribution channel, the hospital segment is forecasted to account for the global market share during the forecast period. The availability of advanced healthcare infrastructure, highly qualified and trained medical professionals, and rising demand for aesthetic Botox procedures strengthen the clostridium botulinum market development.

Clostridium Botulinum Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the global clostridium botulinum market was dominated by North America, followed by Europe. The Asia Pacific is considered to be a lucrative market is expected to grow at a high CAGR.

KEY MARKET PARTICIPANTS:

The top companies dominating the Global Clostridium Botulinum Market profiled in this report are XOMA Ltd., AlphaVax, Inc., Cangene Corporation, Morphotek, Inc., DynPort Vaccine Company LLC, Emergent BioSolutions, Inc., Molecular Targeting Technologies, Inc., and many others.

HAPPENINGS IN THIS MARKET IN THE RECENT PAST:

  • In December 2016, Emergent Biosolutions Inc.'s new drug botulism antitoxin (BAT) received Health Canada approval. The drug BAT is labeled for symptomatic botulism.
  • In February 01, 2019, Evolus, Inc. disclosed as it received the U.S FDA approval for introducing Jeuveau, the first approved neurotoxin committed to aesthetics and manufactured using Hi-Pure technology. 
  • In January 2019, Grupo Dia recalled its canned sardines in olive oil in Spain and Portugal because of botulinum toxin.
  • In June 2016, Revance Therapeutics Inc. acquired a botulinum toxin-related patents and patent applications portfolio. The acquisition has additionally exceeded 70 more patents and patent applications. 

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Botulinum toxin type A      

                                5.1.3 Botulinum toxin type B      

                                5.1.4  Y-o-Y Growth Analysis, By Product              

                                5.1.5  Market Attractiveness Analysis, By Product            

                                5.1.6  Market Share Analysis, By Product              

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Aesthetic 

                                5.2.3 Therapeutics          

                                5.2.4 Y-o-Y Growth Analysis, By application         

                                5.2.5 Market Attractiveness Analysis, By application       

                                5.2.6 Market Share Analysis, By application         

                5.3 Distribution channel                               

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Retail pharmacies 

                                5.3.5 Y-o-Y Growth Analysis, By distribution channel       

                                5.3.6  Market Attractiveness Analysis, By distribution channel    

                                5.3.7  Market Share Analysis, By distribution channel      

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By application

                                                6.1.3.4 By distribution channel

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By application

                                                6.1.4.4 By distribution channel

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By application

                                                6.1.5.4 By distribution channel

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 DynPort Vaccine Company                  

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Emergent BioSolutions, Inc.                

                8.3 XOMA Ltd.                  

                8.4 AlphaVax                     

                8.5 Cangene Corporation                             

                8.6 Morphotek, Inc.                       

                8.7 Morphotek, Inc.                       

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of product and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Clostridium Botulinum Infections Market, By Region, From 2020 to 2025 (USD Million)
  2. Global Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  3. Global Botulinum toxin type A Market, By Region, From 2020 to 2025 (USD Million)
  4. Global Botulinum toxin type B Market, By Region, From 2020 to 2025 (USD Million)
  5. Global Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  6. Global Aesthetic Market, By Region, From 2020 to 2025 (USD Million)
  7. Global Therapeutics Market, By Region, From 2020 to 2025 (USD Million)
  8. Global Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  9. Global Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  10. Global Clinics Market, By Region, From 2020 to 2025 (USD Million)
  11. Global Retail pharmacies Market, By Region, From 2020 to 2025 (USD Million)
  12. North America Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  13. North America Botulinum toxin type A Market, By Region, From 2020 to 2025 (USD Million)
  14. North America Botulinum toxin type B Market, By Region, From 2020 to 2025 (USD Million)
  15. North America Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  16. North America Aesthetic Market, By Region, From 2020 to 2025 (USD Million)
  17. North America Therapeutics Market, By Region, From 2020 to 2025 (USD Million)
  18. North America Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  19. North America Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  20. North America Clinics Market, By Region, From 2020 to 2025 (USD Million)
  21. North America Retail pharmacies Market, By Region, From 2020 to 2025 (USD Million)
  22. United States Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  23. United States Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  24. United States Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  25. Canada Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  26. Canada Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  27. Canada Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  28. Europe Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  29. Europe Botulinum toxin type A Market, By Region, From 2020 to 2025 (USD Million)
  30. Europe Botulinum toxin type B Market, By Region, From 2020 to 2025 (USD Million)
  31. Europe Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  32. Europe Aesthetic Market, By Region, From 2020 to 2025 (USD Million)
  33. Europe Therapeutics Market, By Region, From 2020 to 2025 (USD Million)
  34. Europe Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  35. Europe Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  36. Europe Clinics Market, By Region, From 2020 to 2025 (USD Million)
  37. Europe Retail pharmacies Market, By Region, From 2020 to 2025 (USD Million)
  38. U.K. Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  39. U.K. Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  40. U.K. Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  41. Germany Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  42. Germany Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  43. Germany Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  44. France Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  45. France Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  46. France Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  47. Italy Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  48. Italy Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  49. Italy Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  50. Spain Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  51. Spain Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  52. Spain Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  53. Asia Pacific Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  54. Asia Pacific Botulinum toxin type A Market, By Region, From 2020 to 2025 (USD Million)
  55. Asia Pacific Botulinum toxin type B Market, By Region, From 2020 to 2025 (USD Million)
  56. Asia Pacific Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  57. Asia Pacific Aesthetic Market, By Region, From 2020 to 2025 (USD Million)
  58. Asia Pacific Therapeutics Market, By Region, From 2020 to 2025 (USD Million)
  59. Asia Pacific Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  60. Asia Pacific Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  61. Asia Pacific Clinics Market, By Region, From 2020 to 2025 (USD Million)
  62. Asia Pacific Retail pharmacies Market, By Region, From 2020 to 2025 (USD Million)
  63. Japan Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  64. Japan Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  65. Japan Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  66. China Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  67. China Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  68. China Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  69. India Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  70. India Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  71. India Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  72. Australia Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  73. Australia Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  74. Australia Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  75. South Korea Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  76. South Korea Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  77. South Korea Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  78. Latin America Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  79. Latin America Botulinum toxin type A Market, By Region, From 2020 to 2025 (USD Million)
  80. Latin America Botulinum toxin type B Market, By Region, From 2020 to 2025 (USD Million)
  81. Latin America Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  82. Latin America Aesthetic Market, By Region, From 2020 to 2025 (USD Million)
  83. Latin America Therapeutics Market, By Region, From 2020 to 2025 (USD Million)
  84. Latin America Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  85. Latin America Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  86. Latin America Clinics Market, By Region, From 2020 to 2025 (USD Million)
  87. Latin America Retail pharmacies Market, By Region, From 2020 to 2025 (USD Million)
  88. Brazil Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  89. Brazil Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  90. Brazil Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  91. Argentina Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  92. Argentina Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  93. Argentina Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  94. Mexico Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  95. Mexico Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  96. Mexico Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  97. Rest of Latin America Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  98. Rest of Latin America Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  99. Rest of Latin America Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  100. Middle East and Africa Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  101. Middle East and Africa Botulinum toxin type A Market, By Region, From 2020 to 2025 (USD Million)
  102. Middle East and Africa Botulinum toxin type B Market, By Region, From 2020 to 2025 (USD Million)
  103. Middle East and Africa Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  104. Middle East and Africa Aesthetic Market, By Region, From 2020 to 2025 (USD Million)
  105. Middle East and Africa Therapeutics Market, By Region, From 2020 to 2025 (USD Million)
  106. Middle East and Africa Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  107. Middle East and Africa Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  108. Middle East and Africa Clinics Market, By Region, From 2020 to 2025 (USD Million)
  109. Middle East and Africa Retail pharmacies Market, By Region, From 2020 to 2025 (USD Million)
  110. Middle East Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  111. Middle East Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  112. Middle East Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)
  113. Africa Clostridium Botulinum Infections Market, By Product, From 2020 to 2025 (USD Million)
  114. Africa Clostridium Botulinum Infections Market, By Application, From 2020 to 2025 (USD Million)
  115. Africa Clostridium Botulinum Infections Market, By Distribution channel, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample